Search Ontology:
ChEBI
elvitegravir
- Term ID
- CHEBI:72289
- Synonyms
-
- 6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- elvitegravir
- elvitegravirum
- GS 9137
- GS-9137
- Definition
- A quinolinemonocarboxylic acid that is 7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid substited at position 1 by a 1-hydroxy-3-methylbutan-2-yl group and at position 6 by a 3-chloro-2-fluorobenzyl group (the S-enantiomer). It is used in combination therapy for the treatment of HIV-1 infection.
- References
-
- CAS:697761-98-1
- Drug_Central:4300
- KEGG:D06677
- LINCS:LSM-5647
- PMID:20040702
- PMID:21044030
- PMID:21505303
- PMID:22015077
- PMID:22197635
- PMID:22256860
- PMID:22321026
- PMID:22347806
- PMID:22571404
- PMID:22766666
- PMID:22789987
- PMID:22886031
- PMID:22992351
- PMID:23028968
- PMID:23114768
- PMID:23123342
- PMID:23136357
- PMID:23231029
- PMID:23253887
- PMID:23337366
- PMID:23341902
- PMID:23372110
- Patent:WO2009089263
- Patent:WO2010137032
- Patent:WO2011004389
- Reaxys:10609264
- Wikipedia:Elvitegravir
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from elvitegravir
Phenotype where environments contain elvitegravir
Phenotype modified by environments containing elvitegravir
Human Disease Model